411 related articles for article (PubMed ID: 32347951)
41. Gene-Specific Variation in Colorectal Cancer Surveillance Strategies for Lynch Syndrome.
Kastrinos F; Ingram MA; Silver ER; Oh A; Laszkowska M; Rustgi AK; Hur C
Gastroenterology; 2021 Aug; 161(2):453-462.e15. PubMed ID: 33839100
[TBL] [Abstract][Full Text] [Related]
42. Lynch syndrome-related non-endometrioid endometrial cancer: analysis of outcomes.
Bogani G; Tibiletti MG; Ricci MT; Carnevali I; Liberale V; Paolini B; Milione M; Vitellaro M; Murgia F; Chiappa V; Ditto A; Ghezzi F; Raspagliesi F
Int J Gynecol Cancer; 2020 Jan; 30(1):56-61. PubMed ID: 31780564
[TBL] [Abstract][Full Text] [Related]
43. Germline mutation prevalence in individuals with pancreatic cancer and a history of previous malignancy.
Dudley B; Karloski E; Monzon FA; Singhi AD; Lincoln SE; Bahary N; Brand RE
Cancer; 2018 Apr; 124(8):1691-1700. PubMed ID: 29360161
[TBL] [Abstract][Full Text] [Related]
44. Identification of a Variety of Mutations in Cancer Predisposition Genes in Patients With Suspected Lynch Syndrome.
Yurgelun MB; Allen B; Kaldate RR; Bowles KR; Judkins T; Kaushik P; Roa BB; Wenstrup RJ; Hartman AR; Syngal S
Gastroenterology; 2015 Sep; 149(3):604-13.e20. PubMed ID: 25980754
[TBL] [Abstract][Full Text] [Related]
45. Inequities in multi-gene hereditary cancer testing: lower diagnostic yield and higher VUS rate in individuals who identify as Hispanic, African or Asian and Pacific Islander as compared to European.
Ndugga-Kabuye MK; Issaka RB
Fam Cancer; 2019 Oct; 18(4):465-469. PubMed ID: 31531760
[TBL] [Abstract][Full Text] [Related]
46. Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database.
Dominguez-Valentin M; Sampson JR; Seppälä TT; Ten Broeke SW; Plazzer JP; Nakken S; Engel C; Aretz S; Jenkins MA; Sunde L; Bernstein I; Capella G; Balaguer F; Thomas H; Evans DG; Burn J; Greenblatt M; Hovig E; de Vos Tot Nederveen Cappel WH; Sijmons RH; Bertario L; Tibiletti MG; Cavestro GM; Lindblom A; Della Valle A; Lopez-Köstner F; Gluck N; Katz LH; Heinimann K; Vaccaro CA; Büttner R; Görgens H; Holinski-Feder E; Morak M; Holzapfel S; Hüneburg R; Knebel Doeberitz MV; Loeffler M; Rahner N; Schackert HK; Steinke-Lange V; Schmiegel W; Vangala D; Pylvänäinen K; Renkonen-Sinisalo L; Hopper JL; Win AK; Haile RW; Lindor NM; Gallinger S; Le Marchand L; Newcomb PA; Figueiredo JC; Thibodeau SN; Wadt K; Therkildsen C; Okkels H; Ketabi Z; Moreira L; Sánchez A; Serra-Burriel M; Pineda M; Navarro M; Blanco I; Green K; Lalloo F; Crosbie EJ; Hill J; Denton OG; Frayling IM; Rødland EA; Vasen H; Mints M; Neffa F; Esperon P; Alvarez K; Kariv R; Rosner G; Pinero TA; Gonzalez ML; Kalfayan P; Tjandra D; Winship IM; Macrae F; Möslein G; Mecklin JP; Nielsen M; Møller P
Genet Med; 2020 Jan; 22(1):15-25. PubMed ID: 31337882
[TBL] [Abstract][Full Text] [Related]
47. Family history of cancer predicts endometrial cancer risk independently of Lynch Syndrome: Implications for genetic counselling.
Johnatty SE; Tan YY; Buchanan DD; Bowman M; Walters RJ; Obermair A; Quinn MA; Blomfield PB; Brand A; Leung Y; Oehler MK; ; Kirk JA; O'Mara TA; Webb PM; Spurdle AB
Gynecol Oncol; 2017 Nov; 147(2):381-387. PubMed ID: 28822557
[TBL] [Abstract][Full Text] [Related]
48. Power of pedigree likelihood analysis in extended pedigrees to classify rare variants of uncertain significance in cancer risk genes.
Rosenthal EA; Ranola JMO; Shirts BH
Fam Cancer; 2017 Oct; 16(4):611-620. PubMed ID: 28534081
[TBL] [Abstract][Full Text] [Related]
49. Germline MLH1 and MSH2 mutations in Italian pancreatic cancer patients with suspected Lynch syndrome.
Gargiulo S; Torrini M; Ollila S; Nasti S; Pastorino L; Cusano R; Bonelli L; Battistuzzi L; Mastracci L; Bruno W; Savarino V; Sciallero S; Borgonovo G; Nyström M; Bianchi-Scarrà G; Mareni C; Ghiorzo P
Fam Cancer; 2009; 8(4):547-53. PubMed ID: 19728162
[TBL] [Abstract][Full Text] [Related]
50. Mismatch repair gene mutation analysis and colonoscopy surveillance in Chinese Lynch syndrome families.
Fu L; Sheng JQ; Li XO; Jin P; Mu H; Han M; Huang JS; Sun ZQ; Li AQ; Wu ZT; Li SR
Cell Oncol (Dordr); 2013 Jun; 36(3):225-31. PubMed ID: 23640085
[TBL] [Abstract][Full Text] [Related]
51. Influence of family history on penetrance of hereditary cancers in a population setting.
Jackson L; Weedon MN; Green HD; Mallabar-Rimmer B; Harrison JW; Wood AR; Ruth KS; Tyrrell J; Wright CF
EClinicalMedicine; 2023 Oct; 64():102159. PubMed ID: 37936660
[TBL] [Abstract][Full Text] [Related]
52. Prospective results of surveillance colonoscopy in dominant familial colorectal cancer with and without Lynch syndrome.
Dove-Edwin I; de Jong AE; Adams J; Mesher D; Lipton L; Sasieni P; Vasen HF; Thomas HJ
Gastroenterology; 2006 Jun; 130(7):1995-2000. PubMed ID: 16762622
[TBL] [Abstract][Full Text] [Related]
53. Cancer spectrum in DNA mismatch repair gene mutation carriers: results from a hospital based Lynch syndrome registry.
Pande M; Wei C; Chen J; Amos CI; Lynch PM; Lu KH; Lucio LA; Boyd-Rogers SG; Bannon SA; Mork ME; Frazier ML
Fam Cancer; 2012 Sep; 11(3):441-7. PubMed ID: 22714864
[TBL] [Abstract][Full Text] [Related]
54. Medically actionable pathogenic variants in a population of 13,131 healthy elderly individuals.
Lacaze P; Sebra R; Riaz M; Tiller J; Revote J; Phung J; Parker EJ; Orchard SG; Lockery JE; Wolfe R; Strahl M; Wang YC; Chen R; Sisco D; Arnold T; Thompson BA; Buchanan DD; Macrae FA; James PA; Abhayaratna WP; Lockett TJ; Gibbs P; Tonkin AM; Nelson MR; Reid CM; Woods RL; Murray AM; Winship I; McNeil JJ; Schadt E
Genet Med; 2020 Nov; 22(11):1883-1886. PubMed ID: 32606442
[TBL] [Abstract][Full Text] [Related]
55. Cost-effectiveness Analysis of Genotype-Specific Surveillance and Preventive Strategies for Gynecologic Cancers Among Women With Lynch Syndrome.
Wright JD; Silver ER; Tan SX; Hur C; Kastrinos F
JAMA Netw Open; 2021 Sep; 4(9):e2123616. PubMed ID: 34499134
[TBL] [Abstract][Full Text] [Related]
56. Analysis of 11 candidate genes in 849 adult patients with suspected hereditary cancer predisposition.
Cavaillé M; Uhrhammer N; Privat M; Ponelle-Chachuat F; Gay-Bellile M; Lepage M; Molnar I; Viala S; Bidet Y; Bignon YJ
Genes Chromosomes Cancer; 2021 Feb; 60(2):73-78. PubMed ID: 33099839
[TBL] [Abstract][Full Text] [Related]
57. The role of hereditary nonpolyposis colorectal cancer in the management of familial ovarian cancer.
Farrell C; Lyman M; Freitag K; Fahey C; Piver MS; Rodabaugh KJ
Genet Med; 2006 Oct; 8(10):653-7. PubMed ID: 17079882
[TBL] [Abstract][Full Text] [Related]
58. Identification and Characterization of New
Bouras A; Leone M; Bonadona V; Lebrun M; Calender A; Boutry-Kryza N
Genes (Basel); 2021 Oct; 12(11):. PubMed ID: 34828342
[TBL] [Abstract][Full Text] [Related]
59. RAD51C germline mutations in breast and ovarian cancer cases from high-risk families.
Clague J; Wilhoite G; Adamson A; Bailis A; Weitzel JN; Neuhausen SL
PLoS One; 2011; 6(9):e25632. PubMed ID: 21980511
[TBL] [Abstract][Full Text] [Related]
60. Whole-exome sequencing of non-BRCA1/BRCA2 mutation carrier cases at high-risk for hereditary breast/ovarian cancer.
Felicio PS; Grasel RS; Campacci N; de Paula AE; Galvão HCR; Torrezan GT; Sabato CS; Fernandes GC; Souza CP; Michelli RD; Andrade CE; Barros BDF; Matsushita MM; Revil T; Ragoussis J; Couch FJ; Hart SN; Reis RM; Melendez ME; Tonin PN; Carraro DM; Palmero EI
Hum Mutat; 2021 Mar; 42(3):290-299. PubMed ID: 33326660
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
